Todos Medical Ltd (OP: TOMDF )
0.0010 UNCHANGED Streaming Delayed Price Updated: 3:58 PM EDT, Mar 24, 2023 Add to My Watchlist
Headline News about Todos Medical Ltd
Meet The Company Developing Advanved Blood Tests To Detect Cancer And Other Diseases
August 11, 2022
Gerald Commisiong, CEO of Todos Medical Ltd. (OTCQB: TOMDF), was a guest speaker at Benzinga’s All Access on August 5th, 2022. Todos Medical is a leading in vitro diagnostics company developing of...
Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength including 5 Day Dosing, 30 Day Dosing And 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim
May 02, 2022
5-day and 30-day dosing regimen for 60-pill bottle allows for both support (5-day dosing) to reduce 3CL protease levels and to maintain (30-day dosing) low 3CL protease levels
New Study Reportedly Calls Into Question Merck's Ivermectin COVID Off Label Use And May Bolster 3CL Protease Inhibitors Such As Tollovid
April 12, 2022
Photo credit: Todos Medical This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate Of Free Sale With Daily And Acute Dosing On The Label
April 06, 2022
New York, NY, and Tel Aviv, ISRAEL – April 6, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned...
Todos Medical Completes Acquisition Of Key Assets And Intellectual Property From NLC Pharma
March 16, 2022
- Forms new subsidiary, 3CL Pharma, focused on the development and commercialization of 3CL protease-related products including Tollovir™, Tollovid®, Tollovid Daily™ and TolloTest™ for COVID-19 -
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
Photo from Jason Briscoe on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Todos Medical And NLC Pharma Announce Primary And Secondary Endpoints Met In NLC-V-01 Phase 2 Clinical Trial Of Oral Antiviral 3CL Protease Inhibitor Tollovir™ In The Treatment Of Hospitalized COVID-19 Patients
January 27, 2022
Todos Medical Announces Data Lock in Tollovir™ Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
January 24, 2022
Clinical Data will be released Thursday, January 27th, 2022 New York, NY, and Tel Aviv, ISRAEL – January 24, 2021 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...
PEPPERDINE UNIVERSITY HOSTS THE 22ND ANNUAL CELEBRITY FLAG FOOTBALL CHALLENGE®, PRESENTED BY TODOS MEDICAL'S TOLLOVID®
January 19, 2022
In support of First Responders, Military Service Members and Boys and Girls Youth Groups MALIBU, CALIFORNIA January 19, 2022: Working along with the NFL Host Committee, Celebrity...
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
January 18, 2022
New York, NY, and Tel Aviv, ISRAEL – January 18, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today released...
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
January 12, 2022
CEO Fox Business Interview discussing COVID testing and solutions to address the crisis now online at https://video.foxbusiness.com/v/6291325085001#sp=show-clips New York...
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir™ on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
January 11, 2022
“COVID Testing: What Needs to Happen Now to Turn the Corner in 2022” CEO blog released New York, NY, and Tel Aviv, ISRAEL – January 10, 2022 - Todos Medical,...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following